Laine M. Markham, PA-C

Laine Markham practices at University of North Texas Health Science Center at Fort Worth in Fort Worth, Texas.

Laine Markham's NPI, 1326399148, was assigned on September 20, 2012. Laine Markham holds Texas license PA08523.

Laine Markham's primary practice is University of North Texas Health Science Center at Fort Worth, at 855 Montgomery St, Fort Worth, TX 76107 in Tarrant County. The practice phone is (817) 735-2000.

Laine Markham's primary practice is University of North Texas Health Science Center at Fort Worth in Fort Worth, Texas. The medical group on file is UNT Health Clinical Practice Group. Dmand AI also links Laine Markham to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Laine Markham practices. Vendor and product names are available with a free account.

Physician assistant is Laine Markham's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Laine Markham is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Laine Markham is licensed in Texas.

Dmand AI lists sleep apnea and tobacco use among the conditions Laine Markham treats.

CMS data shows 451 Medicare services from Laine Markham across 6 procedure codes in 2024, for 161 Medicare patients. Medicare paid $25,387 for them. Every service was in an office.

CMS counts 161 Medicare patients who saw Laine Markham in 2024. The largest group is 75 to 84, with 61 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Laine Markham's median patient age at 73, with 63% women.

In 2024, Laine Markham wrote 2,929 Medicare Part D claims for 403 patients. 84% of them were for generic drugs. CMS names the drug for 2,753 of them, across 43 drugs with 11 or more claims each, at $710,381 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Laine Markham for performance year 2024, reported through an alternative payment model (APM). Laine Markham accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 31 general payments to Laine Markham from 14 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 88% of the total. Actelion Pharmaceuticals US, Inc. paid the most, $267.

Dmand AI lists 1 award for Laine Markham, most recently STAR Leadership Program/Pilot Projects Fellow in 2019.

Laine Markham is a member of AAPA and ACC.